Aspirin may reduce risk of liver cancer, death from liver disease

Aspirin use seems to be associated with a decreased risk of liver cancer and death from chronic liver disease, according to a large new study. This study included more than 300,000 people aged 50 to 71, who reported their aspirin and nonsteroidal anti-inflammatory drug (NSAID) use and were followed for 10 to 12 years. During that time, more than 400 participants died from chronic liver disease and 250 were diagnosed with liver cancer. Read more here.